Literature DB >> 12365482

Comparison of preference-based utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after treatment of patients with intermittent claudication.

Johanna L Bosch1, Elkan F Halpern, G Scott Gazelle.   

Abstract

The authors compared SF-36 utilities with Health Utilities Index (HUI) utilities (HUI2 and HUI3) assessed in patients with intermittent claudication. A total of 87 patients with intermittent claudication completed the SF-36 and HUI before and 1, 3, and 12 months after revascularization. Utilities were estimated using SF-36 and HUI published algorithms (i.e., both algorithms were based on standard-gamble utilities assessed in random samples of the general population). The utilities were compared using repeated-measures multivariate analysis of variance, paired t tests, and univariate linear regression analyses. Before treatment, the mean SF-36 and HUI3 utilities were the same (0.66 vs. 0.66, P = 0.92) and less than the mean HUI2 utility (0.70, P = 0.02). After treatment, all utilities showed improvement from before treatment (P < 0.05); the gain in utilities from treatment was lowest when using the SF-36 (e.g., 0.74, 0.80, 0.77 at 3 months for the SF-36, HUI2, and HUI3, respectively). The correlations of changes over time of the SF-36 with HUI2 utilities and of the SF-36 with HUI3 utilities were 0.39 and 0.49, respectively. The relationships between the SF-36 and HUI2 or HUI3 utilities were moderate to good (i.e., range-adjusted R2 = 31% to 72%). The results suggest that SF-36 data can be transformed to preference-based utilities and be used for economic evaluation in health care. The gain in utilities from treatment, however, was less for SF-36 utilities than for HUI utilities.

Entities:  

Mesh:

Year:  2002        PMID: 12365482     DOI: 10.1177/027298902236928

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  8 in total

1.  Correlates of health-related quality of life in type 2 diabetes.

Authors:  D J Wexler; R W Grant; E Wittenberg; J L Bosch; E Cagliero; L Delahanty; M A Blais; J B Meigs
Journal:  Diabetologia       Date:  2006-04-29       Impact factor: 10.122

2.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy.

Authors:  J T Langfitt; B G Vickrey; M P McDermott; S Messing; A T Berg; S S Spencer; M R Sperling; C W Bazil; S Shinnar
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 4.147

4.  A longitudinal comparison of 5 preference-weighted health state classification systems in persons with intervertebral disk herniation.

Authors:  Christine M McDonough; Tor D Tosteson; Anna N A Tosteson; Alan M Jette; Margaret R Grove; James N Weinstein
Journal:  Med Decis Making       Date:  2010-11-22       Impact factor: 2.583

5.  Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores.

Authors:  Mark C Hornbrook; Christopher S Wendel; Stephen Joel Coons; Marcia Grant; Lisa J Herrinton; M Jane Mohler; Carol M Baldwin; Carmit K McMullen; Sylvan B Green; Andrea Altschuler; Susan M Rawl; Robert S Krouse
Journal:  Med Care       Date:  2011-03       Impact factor: 2.983

6.  Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients.

Authors:  David Feeny; Lieling Wu; Ken Eng
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

7.  Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.

Authors:  Henk F van Stel; Erik Buskens
Journal:  Health Qual Life Outcomes       Date:  2006-03-25       Impact factor: 3.186

8.  Quality of life in patients with intermittent claudication.

Authors:  A E Harwood; J P Totty; E Broadbent; G E Smith; I C Chetter
Journal:  Gefasschirurgie       Date:  2017-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.